Milan, Italy

Leda Ivanova Bencheva

This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Ospedale San Raffaele S.r.l., Antios Therapeutics, Inc., Irbm S.p.a.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leda Ivanova Bencheva. Retrieved from https://idiyas.com/inventor/leda-ivanova-bencheva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.1

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Leda Ivanova Bencheva - Innovative Inventor from Milan

Introduction: Leda Ivanova Bencheva is a pioneering inventor based in Milan, Italy, known for her groundbreaking contributions to various fields of technology and science.

Latest Patents: Leda Ivanova Bencheva's most recent patents focus on sustainable energy solutions and advanced medical devices, showcasing her versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Leda Ivanova Bencheva has established herself as a leading figure in the innovation landscape, with numerous patents and inventions that have had a significant impact on society.

Collaborations: Throughout her career, Leda Ivanova Bencheva has collaborated with top research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge sharing.

Conclusion: Leda Ivanova Bencheva's passion for pushing the boundaries of what is possible through innovation continues to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…